Thailand Medical Researchers Uncover Genetic Clues in Rare Childhood Liver Cancer
Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 16, 2026 1 hour, 53 minutes ago
Thailand Medical: A new study by Thai medical researchers has revealed critical genetic patterns behind hepatoblastoma, a rare but serious liver cancer affecting young children. The findings offer fresh hope for improving diagnosis, predicting outcomes, and eventually tailoring treatments for patients who currently face limited options.
New genetic insights reveal why some childhood liver cancers are more aggressive and harder to treat
Understanding a Rare but Dangerous Cancer
Hepatoblastoma is the most common liver cancer in children, typically affecting those under five. Despite medical advances, many cases are detected late, when tumors have already grown large or spread, making treatment more difficult. Standard therapies like chemotherapy and surgery can be effective, but outcomes vary widely - especially in high-risk patients.
To better understand why, scientists analyzed tumor samples from 34 Thai pediatric patients. Using advanced genetic sequencing, they examined both small mutations and larger structural DNA changes known as copy number variations (CNVs).
A Surprising Genetic Pattern Emerges
One of the most striking discoveries was that these tumors carried very few traditional mutations - on average just 3.6 per tumor. Instead, the cancer appeared to be driven largely by widespread chromosomal changes. Each tumor showed an average of more than 180 CNVs, indicating that large-scale DNA alterations may play a bigger role than previously thought.
The most frequently mutated genes included KMT2D, CTNNB1, and MUC16. Interestingly, KMT2D mutations were more common in this Thai cohort than CTNNB1 mutations, which are typically dominant in Western populations. This suggests that genetic drivers of cancer may vary across ethnic groups.
Patients with mutations in KMT2D or CTNNB1 tended to have better survival outcomes, hinting that these genes could serve as useful prognostic markers.
Dangerous Deletions Linked to Poor Survival
While some mutations appeared beneficial, others were linked to worse outcomes. The study identified deletions in two genes - FGD4 and ZNF429 - as particularly concerning.
Children whose tumors lacked FGD4 had dramatically shorter survival times. Their disease returned sooner, and overall survival dropped significantly compared to patients without this deletion. Similar patterns were observed with ZNF429 deletions.
Further analysis across multiple external datasets confirmed that FGD4 levels were consistently lower in tumor tissue, strengthening its role as a key factor in disease progression.
Clinical Impact
This Medical News report underscores a crucial takeaway: hepatoblastoma may not behave like most cancers. Instead of being driven by many small mutations, it appears heavily influenced by large genomic disruptions that affect how cells grow and develop.
This insight could shift how doctors approach diagnosis and treatment. Rather than focusing only on mutations, future strategies may include screening for
CNVs and specific gene deletions to better predict patient outcomes.
Potential for Targeted Treatments
The study also identified possible drug targets, including mutations in NRAS and CTNNB1. While these findings are still early and largely based on research in other cancers, they open the door to more personalized therapies in the future.
However, researchers caution that these potential treatments must be validated specifically for hepatoblastoma before clinical use.
Institutions Behind the Breakthrough
The research was conducted by
Thailand Medical scientists from Prince of Songkla University and Mahidol University, Bangkok.
Conclusion
This study provides compelling evidence that hepatoblastoma in Thai children is driven more by large-scale DNA alterations than by traditional mutations. The identification of FGD4 and ZNF429 deletions as markers of poor prognosis represents a major step toward more accurate risk assessment. At the same time, the discovery of population-specific genetic patterns highlights the importance of region-focused research in cancer biology. While more studies are needed to confirm these findings and translate them into treatments, the research lays a strong foundation for precision medicine approaches that could significantly improve survival and quality of life for affected children.
The study findings were published in the peer reviewed journal: Medicina.
https://www.mdpi.com/1648-9144/62/4/764
For the latest Thai medical research, keep on logging to
Thailand Medical News.
Read Also:
https://www.thailandmedical.news/articles/thailand-medical
Share
Tweet
Share
